Enovis CORP (ENOV) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US1940145022
Enovis CORP financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 2.25 bn USD |
| Gross profit | 1.35 bn USD |
| Operating income | -1.12 bn USD |
| EBIT | -1.13 bn USD |
| Net income | -1.18 bn USD |
| Diluted EPS – continuing operations | -20.75 USD |
Full history since 2004, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Enovis CORP
Enovis Corporation, a medical technology company, focuses on developing clinically differentiated solutions in the United States and internationally. It operates through two segments: Prevention and Recovery, and Reconstructive segments. The Prevention and Recovery segment offers rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, electrical stimulators for pain management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions. The Reconstructive segment develops, manufactures, markets, and distributes surgical solutions that restore mobility and improve patient outcomes, which includes a range of differentiated implants, instrumentation, and enabling technologies used in elective and non-elective joint replacement, limb reconstruction, and foot and ankle procedures; and products for the hip, knee, shoulder, elbow, extremity reconstruction and fixation, foot, ankle, and finger, as well as surgical productivity tools. It also manufactures and distributes a range of products which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company distributes its products through independent distributors, direct salespeople, and patients. The company was formerly known as Colfax Corporation. Enovis Corporation was founded in 1995 and is headquartered in Wilmington, Delaware.
More stocks
- Sichuan Furong Technology Co Ltd (603327.SS)
- North Long Dragon New Materials Technology Co. Ltd. A (301357.SZ)
- Yubico AB (YUBICO.ST)
- Transportation & Logistics Systems, Inc. (TLSS)
- Mainstreet Equity Corp. (MEQ.TO)
- Metsa Board Oyj (METSB.HE)
- Italmobiliare SpA (ITM.MI)
- Sunonwealth Electric Machine Industry Co Ltd (2421.TW)
- d'Amico International Shipping SA (DIS.MI)
- Mips AB (MIPS.ST)
- Oil-Dri Corp of America (ODC)
- KCTech Co Ltd (281820.KS)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.